| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 74 |
| 1 | OXALIPLATIN | 15 |
| 2 | BEVACIZUMAB | 11 |
| 3 | PALBOCICLIB | 11 |
| 4 | LETROZOLE | 10 |
| 5 | RIBOCICLIB | 10 |
| 6 | LETROZOLE TABLETS | 9 |
| 7 | FLUOROURACIL | 8 |
| 8 | FLUOROURACIL CREAM, 0.5% | 8 |
| 9 | GABAPENTIN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FUTIBATINIB | 1 | 0.0045 |
| 1 | ERDAFITINIB | 2 | 0.0016 |
| 2 | CAPECITABINE | 74 | 0.0008 |
| 3 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| 4 | TALQUETAMAB-TGVS | 1 | 0.0007 |
| 5 | CALCIUM FOLINATE | 2 | 0.0004 |
| 6 | TIOPRONIN | 1 | 0.0004 |
| 7 | PILOCARPINE HYDROCHLORIDE | 1 | 0.0004 |
| 8 | HYDRALAZINE HYDROCHLORIDE | 1 | 0.0004 |
| 9 | RIBOCICLIB | 10 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 76 |
| 1 | Kinase Inhibitor [EPC] | 23 |
| 2 | Platinum-based Drug [EPC] | 17 |
| 3 | Aromatase Inhibitor [EPC] | 16 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 11 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 6 | Benzodiazepine [EPC] | 6 |
| 7 | Corticosteroid [EPC] | 6 |
| 8 | Microtubule Inhibitor [EPC] | 6 |
| 9 | Osmotic Laxative [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Reducing and Complexing Thiol [EPC] | 1 | 0.0004 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 76 | 0.0003 |
| 2 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Aromatase Inhibitor [EPC] | 16 | 0.0001 |
| 6 | Interleukin-17A Antagonist [EPC] | 4 | 0.0001 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 5 | 0.0001 |
| 9 | Platinum-based Drug [EPC] | 17 | 0.0001 |